Author:
Przygodzki Tomasz,Talar Marcin,Przygodzka Patrycja,Watala Cezary
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Biochemistry,Physiology
Reference19 articles.
1. Bratkovsky SV, Aasum E, Riemersma RA, Myhre ES, Larsen TS (2006) Reduced coronary reserve in response to short-term ischaemia and vasoactive drugs in ex vivo hearts from diabetic mice. Acta Physiol (Oxf) 186:171–177
2. Chen Y, Yang S, Yao W, Zhu H, Xu X, Meng G, Zhang W (2014) Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway. PLoS One 9:e98483
3. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994–996
4. Feletou M, Verbeuren TJ, Vanhoutte PM (2009) Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156:563–574
5. Gwozdz P, Drelicharz L, Kozlovski VI, Chlopicki S (2007) Prostacyclin, but not nitric oxide, is the major mediator of acetylcholine-induced vasodilatation in the isolated mouse heart. Pharmacol Rep 59:545–552